Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Global publication plans

The Lucid Group Futures Academy

A graduate programme designed to recruit the exceptional, so that we deliver the outstanding.

Lucid Group Communications Limited

- PMLiVE

The changing face of medical communications over the past 15 years

As Porterhouse Medical celebrates its 15 year anniversary, joint MD and founder, Brian Parsons reflects on the changes to the medical communications industry over the past decade and a half.

- PMLiVE

Janssen develops digital tools to help automate clinical trials

iSTEP platform combines mobile tech and smart packaging

- PMLiVE

Ipsen’s liver cancer treatment clears phase III trial

Cabometyx on track for new liver cancer indication

Sanofi reception

Sanofi earmarks €170m for new French vaccines facility

Will expand its Val de Reuil production unit

FDA approves new robotic surgery device

Senhance System backed for colorectal and gynaecological operations

- PMLiVE

Smith & Nephew’s Oliver Bohuon plans his departure

He will step down as CEO by the end of 2018 to retire

- PMLiVE

Multichannel in pharma

Get ready for the perfect storm

- PMLiVE

Lighthouse Medical Communications appoints Andy Willmer as managing director

He will lead the Lucid Group's US company

- PMLiVE

It’s Freshers’ week at Lucid Group

Lucid launch their Futures Academy

Lucid Group Communications Limited

- PMLiVE

CHMP recommends Teva’s generic version of Astellas’ Advagraf

Committee backs the drug for transplant rejection prophylaxis

Roche Basel Switzerland

Roche wins CHMP nod for Alecensa licence extensions

Lung cancer monotherapy set for a broader European label

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links